Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression.
about
Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemicGut Microbiota and Lifestyle Interventions in NAFLDGut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of MetabolomicsEpigenetics and nutritional environmental signalsLow-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver diseaseAssociations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults.Egg phospholipids and cardiovascular healthOxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver diseaseShort-Term Hypocaloric High-Fiber and High-Protein Diet Improves Hepatic Steatosis Assessed by Controlled Attenuation ParameterNutritional approaches for managing obesity-associated metabolic diseases.4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics.Dietary intake, nutrition, and fetal alcohol spectrum disorders in the Western Cape Province of South AfricaThe effects of choline on hepatic lipid metabolism, mitochondrial function and antioxidative status in human hepatic C3A cells exposed to excessive energy substrates.A systems biology approach utilizing a mouse diversity panel identifies genetic differences influencing isoniazid-induced microvesicular steatosis.Dysbiosis of the gut microbiota in disease.Effects of choline on health across the life course: a systematic review.Mouse models of liver fibrosis mimic human liver fibrosis of different etiologies.Higher dietary choline intake is associated with lower risk of nonalcoholic fatty liver in normal-weight Chinese women.The Gordian Knot of dysbiosis, obesity and NAFLD.Role of choline deficiency in the Fatty liver phenotype of mice fed a low protein, very low carbohydrate ketogenic diet.Non-alcoholic fatty liver disease, diet and gut microbiota.Choline and Cystine Deficient Diets in Animal Models with Hepatocellular Injury: Evaluation of Oxidative Stress and Expression of RAGE, TNF-α, and IL-1β.The relationship between early-life environment, the epigenome and the microbiota.EDI3 links choline metabolism to integrin expression, cell adhesion and spreadingCholine Deficiency Causes Colonic Type II Natural Killer T (NKT) Cell Loss and Alleviates Murine Colitis under Type I NKT Cell Deficiency.The Potential of Metabolic Imaging.Choline, Its Potential Role in Nonalcoholic Fatty Liver Disease, and the Case for Human and Bacterial GenesGenetic signatures in choline and 1-carbon metabolism are associated with the severity of hepatic steatosisEffects of Choline on DNA Methylation and Macronutrient Metabolic Gene Expression in In Vitro Models of Hyperglycemia.Nutrition in pregnancy: the argument for including a source of choline.Effects of dietary milk- and soya-phospholipids on lipid-parameters and other risk indicators for cardiovascular diseases in overweight or obese men - two double-blind, randomised, controlled, clinical trials.Metabolic characterization of the natural progression of chronic hepatitis B.Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liverAnimal models of non-alcoholic fatty liver disease: current perspectives and recent advances.Metabolomic Fingerprinting in the Comprehensive Study of Liver Changes Associated with Onion Supplementation in Hypercholesterolemic Wistar RatsFormulation and shelf life stability of water-borne lecithin nanoparticles for potential application in dietary supplements field.Current pharmacotherapy for treating pediatric nonalcoholic fatty liver disease.Choline Supplementation Normalizes Fetal Adiposity and Reduces Lipogenic Gene Expression in a Mouse Model of Maternal Obesity.NMR-based Metabolomics Analysis of Liver from C57BL/6 Mouse Exposed to Ionizing Radiation.Nutritional Epigenetics and the Prevention of Hepatocellular Carcinoma with Bioactive Food Constituents.
P2860
Q24563381-F22CE274-7EF0-4B80-BEFB-6B3EC6D446FAQ26749783-50F2242A-3265-4158-AE38-BC53AC9FE33BQ26753047-91AA6696-C1BF-4B4E-BD75-3A15720D5F55Q27002601-F5F134D2-0D6A-4493-BD16-167208AA40DFQ27007233-3934D1F7-B283-42E6-9D0E-6B338BCF4D77Q27302142-AFEE56D8-72A5-4AED-A8C1-D5BB3CA0E38DQ28082796-20DC8E09-1FC7-4BAE-A745-EA3A14E2E0F9Q28396128-6355F27C-5021-4016-8348-EB7B6C3919C4Q28831365-052E9F69-A224-4CC2-B3B5-8BF30099DCEDQ30234850-5CE3BF40-9FE9-4A5A-B603-0990E3BF5861Q30412771-3108E022-49A7-4B69-8562-25B21E4B2F9AQ33769502-5616E334-3E97-4D96-B161-A2E48C5A8DC8Q33963226-10FCF1CB-62F1-43A5-960F-732E75E88483Q34208933-0D83B630-2BAF-49DB-8B8D-89B20C86A148Q34461294-8D68E052-5981-46F7-8110-0AF6E058FE7AQ34482202-D1CE0C41-0584-4168-AF2F-B7DF81F3DD69Q34482519-4A38C672-EF66-4B9C-BEBC-5CD15F339BB4Q34502294-4A926002-C329-49B9-AE06-501D3DDDEDFCQ34956813-62EA47C8-C0BF-4EBF-A716-579DDFD6A7D8Q34979884-369B21A2-1BFE-46E7-A0AB-417B53BDC464Q35728214-C2543C37-A18D-40FF-AC2A-86852B0943F7Q35744933-CA8084C3-5B87-4C31-95E7-7FD05A1F83A7Q35846587-777034E9-A7EC-403A-AF97-067701444017Q36124959-DB1D8647-BB71-439C-BA28-57E7802605C5Q36251478-3FF7CDE5-FE9E-4164-A336-2CCCE92E3AE4Q36392626-D1E79926-2836-463F-9C11-8D226BE8FAACQ36476924-7E53D681-153B-44A2-BD71-EF91B6DFB506Q36710902-F5027351-5380-4E1B-89CF-D4922EBB9F36Q36781210-1C8FC9E3-C4A5-4CF4-9699-E4A5E6191DC6Q36803360-2C4AC856-3018-4692-9C0E-06B1EDC4945BQ36964496-4B737C07-3B48-42FB-95D9-BC7DC52D1A2FQ36994664-B4026B23-BF1C-43B5-8F43-CB2EECAB068EQ37022557-69E8EECD-8FB9-4194-ADEC-B31B4B88C5C9Q37561108-D0531204-ACD0-4BEA-A4A3-41CE10C78FC1Q37690687-216B1ABE-CC74-4B8C-8B92-E71552EA6DC4Q38034567-0B28A6A3-5945-4AEA-9B1E-0BF60ED27B41Q38249022-85D589F8-E849-486C-9461-D823E45D7FAFQ38618527-EDA9900E-82BA-4BF0-9A76-07EEFFBDC01EQ38809120-0DA7D126-728B-498E-ABC0-66A908BC0D3FQ38856299-7BC868CC-4622-4443-9B79-6EB34CFB29DD
P2860
Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Choline metabolism provides no ...... r disease and its progression.
@ast
Choline metabolism provides no ...... r disease and its progression.
@en
type
label
Choline metabolism provides no ...... r disease and its progression.
@ast
Choline metabolism provides no ...... r disease and its progression.
@en
prefLabel
Choline metabolism provides no ...... r disease and its progression.
@ast
Choline metabolism provides no ...... r disease and its progression.
@en
P2860
P1476
Choline metabolism provides no ...... r disease and its progression.
@en
P2093
Karen D Corbin
P2860
P304
P356
10.1097/MOG.0B013E32834E7B4B
P577
2012-03-01T00:00:00Z